
June 27, 2016
WHAT CAN WE DO ABOUT THE HIGH COST OF MULTIPLE SCLEROSIS DRUGS?
An analysis of Medicare Part D prescribing patterns was recently published. Although neurologists comprise only 1.2% of all physicians, they […]